KHARTCHENKO v. THE AMERICAN ONCOLOGIC HOSPITAL, INC.

CourtDistrict Court, D. New Jersey
DecidedOctober 10, 2025
Docket1:23-cv-23043
StatusUnknown

This text of KHARTCHENKO v. THE AMERICAN ONCOLOGIC HOSPITAL, INC. (KHARTCHENKO v. THE AMERICAN ONCOLOGIC HOSPITAL, INC.) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
KHARTCHENKO v. THE AMERICAN ONCOLOGIC HOSPITAL, INC., (D.N.J. 2025).

Opinion

THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY CAMDEN VICINAGE

INNA KHARTCHENKO,

Plaintiff, Civil No. 23-23043 (ESK/EAP) v.

THE AMERICAN ONCOLOGIC HOSPITAL, INC., et al.,

Defendants.

MEMORANDUM OPINION

This matter comes before the Court on Plaintiff Inna Khartchenko’s Motion for Leave to File a Second Amended Complaint, ECF No. 43 (“Pl.’s Mot.”). Defendants, the American Oncologic Hospital, Inc. (“AOH”), the Institute for Cancer Research (named as Fox Chase Cancer Center) (“FCCC”), and Temple University Health System, Inc. (“TUHS”) (collectively, the “Corporate Defendants”), together with individual Defendants Sangeeta Bardhan Cook, John Lasky, Amber Medlin, and Jerome Maddox (all Defendants collectively, “Defendants”) have opposed the Motion, ECF No. 47 (“Defs.’ Opp.”). Plaintiff filed a reply brief in support of her Motion, ECF No. 48 (“Pl.’s Reply”). The Court has reviewed the parties’ submissions and decides this matter without oral argument pursuant to Federal Rule of Civil Procedure 78(b) and Local Civil Rule 78.1. For the following reasons, the motion is GRANTED IN PART and DENIED IN PART. FACTUAL BACKGROUND1 A. The Parties Established in 1904, Defendant AOH was one of the nation’s first cancer hospitals. ECF No. 1-3 (First Am. Compl. (“FAC”)) ¶¶ 14. In 1974, AOH joined with the Institute for Cancer Research and formed FCCC. Id. ¶ 15. In 2012, FCCC became part of TUHS. Id. ¶ 16. Since then, the Corporate Defendants have operated as joint entities to service patients throughout the Greater

Philadelphia region and South Jersey. Id. ¶¶ 17-18. Plaintiff Inna Khartchenko is an immigrant of Russian and Ukrainian origin. Id. ¶ 22. She began her employment with the Corporate Defendants in 2007 as the Associate Director of Business Development, and in 2015, she was promoted to the Director of Technology Transfer. Id. ¶¶ 19-20. In 2018, the Corporate Defendants expanded Plaintiff’s responsibilities to include the New Ventures programs. Id. ¶ 21. According to the FAC, Plaintiff’s employment was without issue until she (1) complained of discriminatory comments made by her direct supervisor, Defendant Sangeeta Bardhan Cook, the Chief Innovation Officer for FCCC and Senior Vice President of Commercialization Strategy and Business Development for TUHS; (2) reported Cook for retaliating

against her by attempting to deny her a necessary medical accommodation; and (3) objected to Defendants’ business dealings with a Russian company. Id. ¶¶ 7, 30. B. Defendant Cook’s Alleged Pattern of Discriminatory Conduct and Retaliation Defendant Cook began her employment with the Corporate Defendants in August 2022. Id. ¶ 36. On October 27, 2022, Cook sent a Microsoft Teams message to Plaintiff about Robert Uzzo,

1 The following facts are taken from the First Amended Complaint. Because Federal Rule of Civil Procedure 12(b)(6) governs the assessment of a proposed amended complaint’s futility, all allegations in the First Amended Complaint and Proposed Second Amended Complaint must be accepted as true. See Cox v. Money Source, Inc., No. 23-20880, 2025 WL 1621984, at *2 (D.N.J. June 9, 2025). Corporate Defendants’ President and Chief Executive Officer, and Jonathan Chernoff, Cancer Center Director, remarking that Uzzo and Chernoff were “two white guys” who only cared about samples from underrepresented patient populations because the National Cancer Institute “forced them” to care. Id. ¶¶ 39-40. According to the First Amended Complaint, over the next several months, Cook made additional comments that Plaintiff found offensive, many of which were of an antisemitic nature.

Id. ¶¶ 44-47. For example, during a December 2022 one-on-one meeting, Cook mentioned Corporate Defendants’ Professor Edna Cukierman, and allegedly asked Plaintiff, “Do you know which PI is the biggest manipulator? It is Eti [Cukierman]. She can play people in such a way that they would not even notice. When I was listening to her at some meetings, I thought that my ex Jewish boyfriends would behave in exactly the same way.” Id. ¶ 45. Plaintiff objected to Cook’s comments, explaining that many of her friends are Jewish and that she grew up with Jewish students and teachers. Id. ¶ 49. Plaintiff further alleges that Cook’s alleged antisemitism “especially offended” her because her grandmother’s parents and young siblings lost their lives in the Holocaust. Id. ¶ 50. Beyond the antisemitic comments, Plaintiff claims that Cook also regularly made harassing

comments about many of Plaintiff’s colleagues, some of which Plaintiff believed showed that Cook had a pattern of discriminating against persons with disabilities. Id. ¶¶ 51-56. In November 2022, Plaintiff went to the emergency room for abdominal pain. Id. ¶ 58. Plaintiff subsequently reported to Cook that she was scheduled for surgery on January 9, 2023. Id. ¶ 59. Although Cook suggested that Plaintiff could take Family and Medical Leave Act (“FMLA”) leave, Plaintiff opted to continue her previous remote work arrangement2 and work throughout her recovery, with sick time taken only as needed. Id. ¶¶ 60-70.

2 According to the FAC, since 2013, Plaintiff had been working a remote hybrid schedule, which was converted to a fully remote schedule at the start of the COVID-19 pandemic. Id. ¶ 61. Between January 12, 2023, and January 27, 2023, Plaintiff worked remotely while using approximately two sick days per week. Id. ¶ 71. During this time, Plaintiff claims to have recognized a change in Cook’s behavior toward her. Id. ¶ 72. According to Plaintiff, Cook began to heavily scrutinize Plaintiff’s work. Id. ¶¶ 73-74. On January 23, 2023, Plaintiff reported Cook’s alleged pattern of discriminatory behavior—focusing on Cook’s alleged antisemitic comments and increased scrutiny of Plaintiff’s work after her surgery—to Cancer Center Director Jonathan

Chernoff. Id. ¶¶ 75-77. Just days later, on January 28, 2023, Cook informed Plaintiff that she had to retroactively use FMLA leave for her sick days after her surgery and that she could not work until she presented a physician’s clearance note. Id. ¶ 78. On January 30, 2023, Cook allegedly began to target Plaintiff’s remote work arrangement and presented Plaintiff with an accommodation form for her physician to sign in order to remain working from home. Id. ¶¶ 80-81. On February 2, 2023, prior to a meeting with Defendant Amber Medlin, Senior Human Resources Business Partner, about her accommodation request, Plaintiff sent a lengthy complaint via email about Cook and her alleged discriminatory remarks and retaliatory behavior. Id. ¶¶ 9, 85. That email detailed Plaintiff’s various complaints of Cook’s retaliation,

including alleged discriminatory remarks, criticism of senior administration and investigators, and efforts to remove Plaintiff’s ability to work from home. Id. ¶ 85. Based on that email, Plaintiff alleges that the “Corporate Defendants purported to investigate [her] complaints and interviewed [her] on February 15, 2023, via Zoom from her home office in New Jersey.” Id. ¶ 86. Although the Corporate Defendants approved Plaintiff’s accommodation request through May 13, 2023, Plaintiff believed that Cook was “beginning the process to revoke Plaintiff’s remote work arrangement.” Id. ¶ 87. During the investigation period, Plaintiff alleges that she suffered stress that contributed to complications from her surgery. Id. ¶¶ 88-89. In the wake of the investigation, Cook allegedly criticized Plaintiff publicly, micromanaged her, made her look incompetent, and excluded her from important meetings. Id. ¶ 90.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Holifield v. Reno
115 F.3d 1555 (Eleventh Circuit, 1997)
McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Elberson v. Comm of PA Gov Ofc
396 F. App'x 819 (Third Circuit, 2010)
Charles Wilcher v. Postmaster General
441 F. App'x 879 (Third Circuit, 2011)
Eugene Farmer v. Philadelphia Electric Company
329 F.2d 3 (Third Circuit, 1964)
Mechele Vinson v. Sidney L. Taylor
753 F.2d 141 (D.C. Circuit, 1985)
Marguerite Hicks v. The Gates Rubber Company
833 F.2d 1406 (Tenth Circuit, 1987)
James W. Woodson v. Scott Paper Co.
109 F.3d 913 (Third Circuit, 1997)
Mayle v. Felix
545 U.S. 644 (Supreme Court, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
KHARTCHENKO v. THE AMERICAN ONCOLOGIC HOSPITAL, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/khartchenko-v-the-american-oncologic-hospital-inc-njd-2025.